Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


ATC
ATC Description

ATC

ATC Code ATC Description
L01FF01 L01FF01 Nivolumab
L01FF02 L01FF02 Pembrolizumab
L01FF03 L01FF03 Durvalumab
L01FF04 L01FF04 Avelumab
L01FF05 L01FF05 Atezolizumab
L01FF06 L01FF06 Cemiplimab
L01FF07 L01FF07 Dostarlimab
L01FF08 L01FF08 Prolgolimab
L01FF09 L01FF09 Tislelizumab
L01FF10 L01FF10 Retifanlimab
L01FF11 L01FF11 Sugemalimab
L01FF12 L01FF12 Serplulimab
L01FF13 L01FF13 Toripalimab
L01FG L01FG VEGF/VEGFR (Vascular Endothelial Growth Factor / -Receptor) inhibitors
L01FG01 L01FG01 Bevacizumab
L01FG02 L01FG02 Ramucirumab
L01FX L01FX Other monoclonal antibodies and antibody drug conjugates
L01FX01 L01FX01 Edrecolomab
L01FX02 L01FX02 Gemtuzumab ozogamicine
L01FX03 L01FX03 Catumaxomab
L01FX04 L01FX04 Ipilimumab
L01FX05 L01FX05 Brentuximab vedotin
L01FX06 L01FX06 Dinutuximab beta
L01FX07 L01FX07 Blinatumomab
L01FX08 L01FX08 Elotuzumab
L01FX09 L01FX09 Mogamulizumab
L01FX10 L01FX10 Olaratumab
L01FX11 L01FX11 Bermekimab
L01FX12 L01FX12 Tafasitamab
L01FX13 L01FX13 Enfortumab vedotin
Showing 30 of 6884 Records